Anlai Wang
Incyte (United States)(US)
Publications by Year
Research Areas
Cyclization and Aryne Chemistry, Immune Cell Function and Interaction, Glycosylation and Glycoproteins Research, Peptidase Inhibition and Analysis, Synthesis and pharmacology of benzodiazepine derivatives
Most-Cited Works
- → Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma(2010)553 cited
- → Functional Isolation and Characterization of Human Hematopoietic Stem Cells(1995)404 cited
- → Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344(2005)188 cited
- → Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells(2020)111 cited
- → Discovery of NVP‐LEQ506, a Second‐Generation Inhibitor of Smoothened(2013)88 cited
- → Identification of a regulatory autophosphorylation site in the serine–threonine kinase RIP2(2006)76 cited
- → Participation of Rip2 in Lipopolysaccharide Signaling Is Independent of Its Kinase Activity(2005)76 cited
- → Recombinant Human Interleukin-11 Directly Promotes Megakaryocytopoiesis In Vitro(1997)74 cited
- → Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop(2006)72 cited
- → Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist(2011)48 cited